In the context of pancreatic cancer, ZEB1 stands out as a significant contributor to the EMT because of its ability to seamlessly transition between a transcriptional repressor and activator, depending on how it interacts with co-activators like Lef1, YAP1, P300, and Smad [46,47]. Here, ZEB1 is linked to pancreatic neoplasm.